Volume 3, Issue 2 (9-2016)                   jhbmi 2016, 3(2): 100-117 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jafarinezhad S, Dehghani Ashkezari M, Jebali A. The Study of Interactions between Amyloid-Beta Precursor Protein and Functional Nanomotors as a New anti-Alzheimer's Disease Strategy by Modeling and Computer Simulation. jhbmi 2016; 3 (2) :100-117
URL: http://jhbmi.ir/article-1-141-en.html
Ph.D. in Medical Nanotechnology Assistant Professor, Medical Biotechnology Research Center, Islamic Azad University-Ashkezar Branch, Ashkezar, Yazd, Iran.
Abstract:   (6650 Views)

Introduction: The aim of this study was to evaluate the performance of three nanomotors on 15 transmembrane amyloid-beta precursor proteins by molecular dynamics simulation.

Method: In this study, 15 transmembrane APP (14 mutant forms and one normal) were obtained from National Center for Biotechnology Information (NCBI) and separately modeled in Designer Ascalaph. The synthesized peptides with three-dimensional stable structures were selected to be simulated and then were placed near synthesized nanomotors, hypericin, and retinol using HyperChem. At end of simulation, different parameters such as free energy, intermolecular energy, potential energy, and root mean square displacement (RMSD) were separately obtained for each APP. Finally, the ratio of changes was calculated for each parameter.

Results: The results showed that each nanomotor had different performance on different peptides. Hypericin on peptide 5, retinol on peptide 10, and nanomotors partly on peptide 4 had a great performance. But because each nanomotor influences only special mutant peptide and Alzheimer's disease is caused by different mutations, only one type of nanomotors cannot be used to treat Alzheimer's disease.

Conclusion: According to the investigations performed on the treatment of Alzheimer’s disease, it can be concluded that retinol with three-dimensional structure and dynamic parameters has great performance on transmembrane mutant peptide; therefore, it can be considered as a useful treatment strategy.

Full-Text [PDF 1882 kb]   (2570 Downloads)    
Type of Study: Original Article | Subject: Special
Received: 2016/07/6 | Accepted: 2016/09/8

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Health and Biomedical Informatics

Designed & Developed by : Yektaweb